Drugs for enlarged prostate can up depression, self-harm risk in rare case: study
TORONTO — A common class of medications used to treat urinary symptoms in men with an enlarged prostate does not boost the risk of suicide, but in rare cases can cause depression and thoughts of self-harm, a study has found.
Researchers decided to investigate the potential adverse effects of finasteride and dutasteride after Health Canada issued a warning last year about a possible relationship between the drugs and suicidal behaviour.
These drugs, known as 5-alpha reductase inhibitors, or 5ARIs, work by shrinking the prostate, a walnut-sized gland that wraps around the urethra, the tube from the bladder through which urine is voided. When the prostate becomes enlarged, it can cause such symptoms as difficulty urinating or in some cases urinary frequency and urgency, often during the night.
“Our study shows that 5-alpha reductase inhibitors do not lead to an increased risk of suicide,” said Dr. Blayne Welk, a urologist at Western University in London, Ont., who led the study published Monday in the journal JAMA Internal Medicine.


